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Hyperproliferative diseases of the epidermal keratinocytes, 
such as psoriasis vulgaris, are characterized by overexpression 
and altered distribution of the epidermal growth factor/ 
transforming growth factor (EG F /TG F)-a receptor, and of 
TGF-a itself. It is believed that overexpression of this lig-
nad/receptor system contributes to the hyperproliferative 
state ofkeratinocytes in an autocrine fashion. However, little 
is known about the factors that regulate expression of the 
EGF /TGF-a receptor, as well as expression of TGF-a in 
stratified epithelium. We examined modulation of the immu-
noreactive EGF/TGF-a receptor and TGF-a eXfression in 
normal neonatal foreskin explants by a variety 0 cytokines 
present in psoriatic lesions. Human (l1U) recombinant (r) 
tumor necrosis factor (TNF)-a and interferon (IFN)-y in-
duced EGF/TGF-a receptor and TGF-a expression by kera-
tinocytes as determined by immunohistochemistry. Neut~al­
izing antibodies to TNF-a and IFN-y inhibited upregulatlOn 
ofEGF /TGF-a receptors and TGF-a by the respective cyto-
kines. Interleukin (IL)-8 induced expression of TGF-a, but 
not of its receptor. Other cytokines (TNF-P, IFN-P, IL-l~, 
IL-2, IL-3, IL-S, IL-6, granulocyte/macrophage colony-sU-
mulating factor, and macrophage colony-stimulating factor) 
did not alter the expression patterns of EGF/TGF-a recep-
tors or TGF-a in normal neonatal skin explants. These eX-
periments demonstrate that specific cytokines known t? be 
present in psoriatic lesions can induce normal epidermIS to 
express TGF-a and its receptor in a pattern similar to that 
observed in psoriatic skin. ] Invest Dermato! 99:350-356, 
1992 
---------------------------------------------------------------------------------------------------------
T he epidermis is one of the few tissues that is mitoti-cally active throughout the lifespan of the organism. Two structurally and functionally related growth fac-tors, epidermal growth factor (EGF) and transform-ing growth factor-a (TGF-a), appear to contribute to 
the proliferation of normal human keratinocytes during embryo-
logic development and in tissue culture [1,2]. Addition ofTGF-a to 
cultured keratinocytes not only stimulates growth, but also induces 
endogenous TGF-a production, which is likely to amplify the 
growth response to exogenous TGF-a [3] . Proliferative effects of 
both growth factors, EGF and TGF-a, are mediated by activation of 
the tyrosine kinase moiety of the EGF /TGF-a receptor [4,5] that is 
expressed on the surface of keratinocytes in vivo and in vitro [6). 
Inhibition of the EG F /TG F-a receptor tyrosine kinase activity re-
sults in inhibition of keratinocyte proliferation [4]. Conversely, 
constitutive overexpression of TGF-a in the skin of transgenic 
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mice, under the control of the human keratin K14 promoter, leads 
to epidermal thickening, reflecting increases in keratinocyte nU.m-
bers and cell hypertrophy [7]. These results indicate an autocrlne 
role for TGF-a in keratinocyte growth in vivo. . 
Activation of the TGF-a - dependent autocrine loop in keratlllO-
cytes may be regulated by cytokines. Various cytokines, such ad 
interleukin (IL)-1 [8], tumor necrosis factor-alpha (TNF-a) [9], an 
interferon-gamma (IFN-y) [10,11]' have been shown to increase 
steady-state TGF-a mRNA levels in cultured keratinocytes. In ~d­
dition, IFN-y appears to modulate EGF-receptor protein expreSSIOn 
of cultured keratinocytes. Both increased [12] and decreased [13} 
EGF-receptor expression was observed after IFN-y treatment 0 
keratinocytes in culture. . 
However, studies with cultured keratinocytes cannot mimic the 
potential complex interactions between cells of different types nor 
between keratinocytes in distinct differentiation states. We haver 
therefore, examined the effect of various cytokines on the pattern 1-
expression of TGF-a and the EGF /TGF-a receptor in organ cU 
tures of normal neonatal skin. 
MATERIALS AND METHODS 
Organ Culture Short-term organ cultures of skin samples -:vere 
carried out as described [14,15] with minor modifications. BrJ~Y' 
neonatal foreskins, obtained from four donors, were immerse. cill 
MCDB 153 medium containing 0.03 mM calcium, amino aCd s~ ethanolamine, phosphoethanolamine, and hydrocortisone as e 
scribed, but no pituitary extract or polypeptide growth factors (~r 
medium) [16]. After removal of fatty tissue from the dermal 51 ed 
skin samples were cut into approximately 2-mm square pieces an 
placed epidermal surface up in wells of 6-well tissue culture plates. 
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Base medium (approximately 800,u1) containing cytokines was 
added. The epidermal surface of explants remained uncovered by 
cUlture medium. Explants were incubated at 37"C in a humidified 
Incubator. In control cultures medium was not supplemented with 
cy~okines, or cytokines were mixed with neutralizing antibodies 
pnor to addition to cultures. Explants were harvested after 24 h, 
embedded in OCT compound (Tissue-Tek, Miles, Inc., Elkhart, 
IN) , and snap-frozen at - 70°C. 
Cytokines, Antibodies, and Immunohistochemistry Ex-
plants were incubated with the following cytokines at different 
concentrations: human (hu) recombinant (r) IL-8 (Pepro Tech Inc., 
Rocky Hill, NJ) at 5, 10, and 25 ng/ml; hu rTNF-O' (Genentech, 
San Francisco, CA) at 500, 1,000, and 10,000 U/ml; hu rIFN-y 
(Genentech) at 500,1,000, and 10,000 U/ml; hu rIL-IO' (Genetics 
Institute, Cambridge, MA) at 25, '50, and 100 U /ml; hu r granulo-
cyte/macrophage colony-stimulating factor (Genetics Institute) at 
1,000 and 10,000 U/ ml; hu r macrophage colony-stimulating fac-
~or (Genetics Institute) at 1,000 and 10,000 U /ml; hu rIL-3 (Genet-
ICS Institute) at 700 and 1,400 U /ml; hu rIL-5 (Genetics Institute) at 
50, 100, and 500 U /ml; hu rIL-6 (Genetics Institute) at 10, 20, and 
4~ U/ml (Genetics Institute); hu rTNF-p (Cetus Corp., Emory-
vdle, CA) at 1,000 and 10,000 U/ml; and hu rIFN-P (Genentech) 
at 1,000 and 10,000 U /m!. For blocking experiments, neutralizing 
monoclonal antibodies (MoAb) to TNF-O' (MoAb 154.2.1) and 
IFN_y (mAb B33.31), kindly provided by Dr. G. Trinchieri, were 
Usedsimultaneously with cytokines at 1: 200 and 1 : 400 dilutions of 
aSCitic fluid. . 
For immunohistochemical staining, unfixed, 4-6 ,urn thick fro-
zen sections were incubated for 1 h with MoAb recognizing hu 
TGF-O! (Ab2; Oncogene Science, Inc. , Manhasset, NY) and the 
EGF /TGF-O' receptor (MoAb 425) [17] at 5 and 10 ,ug/ml, respec-
tively. Ab2 recognizes huTGF-O! in its free and receptor-bo~nd 
form (communication by Oncogene Science). MoAb 425 [18] bmds 
specifically to a protein epitope on the external domain of the hu 
EGF/TGF_O! receptor. It immunoprecipitates a 170-kDa protem 
fr?m35S_labeled A 431 cells, recognizes a 32P-labeled 170-kDa pro-
tem in EGF-stimulated A 431 squamous carcinoma cells and pla-
cental membranes, and binds to the proteolytically cleaved 1 ~O-kDa 
external domain ofhu EGF /TGF-O! receptor [18]. It recogmzes th.e 
occupied as well as the unoccupied EGF /TGF-O! receptor because It 
Immunoprecipitates a 1251-EGF/170-kDa complex from various 
human cell lines and tissues [18] . Scatchard analysis demonstrated 
that MoAb 425 binds to high- and low-affinity EGF/TGF-c::" recep-
tors with kinetics very similar to EGF itself [18]. No prot.ell~ other 
than the EGF/TGF-O! receptor is detected by MoAb 425 m Immu-
noprecipitation analyses of cell membrane preparations of A 431 
squamous carcinoma cells. 
. Antibody binding was visualized using a fluorescein 
Isothiocyanate-Iabeled goat anti-mouse immunoglobulin G at 
1: 100 dilution Qackson ImmunoResearch, West Grove, PA). Cy-
~okine-treated organ cultures were evaluated parallel to samples 
InCUbated with cytokines and antibodies. 
In order to demonstrate viability of the organ cultures, immu~o­
per?xidase staining of sections was performed usin~ antibodies 
agamst endothelial cell adhesion molecules, one of wll1ch has been 
preViously shown to be upregulated by cytokines in orga.n cultl~re 
l14] . Control and TNFO!-stimulated cultures were thus stamed with 
an anti - PECAM-l / endoCAM MoAb that specifically·identifies all 
endothelial cells in tissue sections [19,20] and with an anti-E-
selectin (ELAM-l) antibody H4/18 [14], kindly provided by Dr. ~lchael Bevilacqua. The bound first antibody was detected by the 
ectastain ABC Elite kit (Vector Laboratories, Burlingame, CA) 
With AEc as chromagen. No counterstain was applied in order to 
Increase sensitivity. Photographs were taken with a Zeiss Photomi-
croscope III, using Kodak T-MAX 100 film. 
RESULTS 
Morphology and Viability of Skin Explants After 24 h of 
organ culture, the keratinocytes appeared intact and similar in ap-
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pearance to normal skin after hematoxylin-eosin staining (Fig lA). 
To confirm cellular viability, sections were stained with antibodies 
that specifically recognize endothelial cell adhesion molecules. The 
entire vasculature of the graft was visualized using the anti-
PECAM-l MoAb (Fig IB), and illustrates that the endothelium was 
intact and expressing normal cell surface antigens. To determine if 
these cells could respond to cytokine stimulation, sections of organ 
cultures exposed to base medium (Fig le) and cultures exposed to 
10,000 units of TNF-O! (Fig ID) for 24 h were stained for the 
presence of E-selectin. Although E-selectin was completely absent 
in control sections (Fig le), a small percentage of vessels in the 
TNF-O!-treated culture showed clear expression ofE-selectin (ar-
rowheads in Fig ID) . This relatively weak, but significant, upregula-
tion of E-selectin at 24 h is similar to that reported by Messadi et al 
[14]. 
Effects ofTNF-O! and IFN-y on TGF-O' and EGF /TGF-O' Re-
ceptor Expression in Skin Explants Following 24 h of incu-
bation with MCDB 153 base medium containing 0.03 mM cal-
cium, amino acids, ethanolamine, phosphoethanolamine, and 
hydrocortisone, but no cytokines, a low-grade (2+) expression of 
TGF-O' was detected predominantly in the intermediate and upper 
layers and, to a lesser degree, in the basal-suprabasal region of skin 
explants (Figs 2A and 4A). After incubating samples with 1000 U / 
ml TNF-O' for 24 h, a marked increase in TGF-O! expression (4+) 
was noted in the intermediate and upper skin layers (Fig 2B). Also, 
in a few sectors, basal and suprabasal keratinocytes showed increased 
staining (2+) for TGF-O' (Fig 2B). Upregulation ofTGF-O' was also 
observed when samples were treated with 500 U /ml of TNF-O' 
(not shown). Expression ofTGF-O' was somewhat reduced, as com-
pared to untreated controls (Fig 2e), when explants were incubated 
simultaneously with TNF-O! and MoAb 154.2.1, a neutralizing an-
tibody to TNF-O'. 
Incubation with IFN-y at 1000 U /ml, but not at 500 U /ml, simi-
larly resulted in higher expression of TGF-O', although staining 
intensity was less (3+) than that observed after addition ofTNF-O! 
(Fig ID). Incubation with IFN-yin the presence of MoAb B33 .' 1, a 
neutralizing antibody to IFN-y, prevented the upregulatiO! <)f 
TGF-O' expression (Fig lE). 
Expression of the EGF/TGF-O' receptor was confined to basal-
suprabasal cells in untreated control samples (Fig 3A). Following 
incubation with either TNF-O' (500 or 1000 U/ml) or IFN-y 
(1000 U /ml), keratinocytes in all layers of the epidermis were 
evenly stained for the EGF /TGF-O! receptor (Fig 3B,D). Similar to 
results described for TGF-O!, upregulation of the EGF/TGF-O! re-
ceptor could not be observed when TNF-O'- or IFN-y-induced ef-
fects were inhibited with the respective neutralizing antibody (Fig 
3C, E). Furthermore, treatment of cultures with the TNF-O' anti-
body alone resulted in reduced staining for the EG F /TG F-O' recep-
tor when compared to untreated controls, suggesting that endoge-
nous TNF-O' may contribute to EGF/TGF-O' receptor expression. 
Effect ofIL-8 on TGF-O! and EGF /TGF-O! Receptor Expres-
sion in Skin Explants Treatment of skin explants with 5 ng/ml 
hu rIL-8 resulted in a marked upregulation ofTGF-O! in all layers of 
the epidermis (4+ versus 1 or 2+ in controls) (Fig 4A,B). Similar to 
results obtained with IFN-y, basal and suprabasal cells stained only 
weakly for TGF-O! in control cultures. No modulation of EGF/ 
TGF-O' receptor expression by IL-8 was observed in three consecu-
tive experiments carried out on tissues from different donors (not 
shown). 
Effects of Other Cytokines on TGF-O' and EGF /TGF-O' Re-
ceptor Expression in Skin Explants No stimulation ofTGF-O! 
and EG F /TG F-O! receptor expression was detected in four consecu-
tive experiments using material from different donors when skin 
explants were treated with hu rIL-IO!, IL-3, IL-5, or IL-6. Similarly, 
TNF-P, IFN-P, macrophage/colony-stimulating factor, and granu-
locyte macrophage/colony-stimulating factor were ineffective 
when tested in three separate experiments. 
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Figure 1. Morphology and viability of skin explants. Skin explants were stained after 24 h of organ culture. Hematoxylin-eosin staining reveals th~t :~~ 
keratinocytcs are normal in appearance (A). The microvasculature of the explants were visualized by immunohistochemical staining with the endo~ e its 
cell-specific antibody PECAM-l (B). The viability of the cells within the explants was determined by exposing organ cultures to base medium or 10,00 f~he 
ofTNF-a for 24 h and then staining for the inducible endothelial cell adhesion molecule, E-selectin. No expression ofE-selectin was seen on the vessel~~ J1.t11. 
control cu lture (C). In contrast, clear expression of E-selectin (arrowheads) was seen in some of the vessels in the TNF-a-treated graph (D) . Bars, 
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Figure 2. TGF-a expression of neonatal skin explant cultures treated with 
IFN -y or TNF-a. Explants were incubated in MCDB 153 base medium with 
no cytokine additive (A), or in the presence ofTNF-a (B) or IFN-y (D); on 
B, arrowheads point at TGF-a-positive areas in the basal-suprabasal region. 
C and E show inhibition of cytokine-induced TGF-a expression by neutral-
izing antibodies to TNF-a and IFN-y, respectively. Bars, 30 jim. 
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Figure 3_ EGF-receptor expression of neonatal skin explant cultures treated 
with IFN-yorTNF-a. Explants were incubated in MCDB 153 base rnedlurn 
with no cytokine additive (A), or in the presence ofTNF-a (B) or IFN-Y 
(D). C and E show inhibition of cytokine-induced EGF-receptor expressiOn 
by neutralizing antibodies to TNF-a and IFN-y, respectively. Bars, 30 Jirn. 
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Ftgure 4. Induction of TGF-a expression in skin explants by IL-8. Ex-
p ants were incubated inMCDB base medium alone (AJ or 111 the presence 
of IL-8 (B J. Bars, 30,um. 
DISCUSSION 
In Contrast to earlier studies on cultured keratinocytes, Out experi-
rnents evaluated the cytokine-induced upregulation ofTGF-a and 
Its receptor on keratinocytes in situ. This approach takes into ac-
COUnt that the net result of cytokine-mediated effects may be criti-
cally dependent on the complex interaction of different cell types 
bnd distinct differentiation states that are present in stratified skin, 
Ut absent in keratinocyte cu ltures. 
E The cytokine-induced expression pattern of immunoreactive 
GF /TG F-a receptors in normal neonatal skin is strikingly similar 
to the pattern observed in active psoriatic lesions. In stratified nor-
~al epithelium, expression of immunoreactive EGF /TGF-a recep-
([o;s IS restricted to basal and immediate suprabasal keratinocytes 
. 1] and this study) . However, in active psoriatic lesions, expres-
Sl~n of EGF receptors is observed not only in the basal but also in the 
sb.comeal layers of stratified epithelium [6,22], reminiscent of the 
~ IqUltouS expression ofEGF /TGF-a receptors in fetal skin [21]. In 
11s study, TNF-a and IFN-y treatment of skin explants produced a 
uniform expression of EGF /TGF-a receptors across all nucleated 
1trata of the epidermis, similar to the pattern observed in psoriatic 
eS10ns Or fetal epidermis. 
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Expression of immunoreactive TGF-a protein has been reported 
to be generally enhanced, but not significantly redistributed, in 
active psoriatic lesions when compared to normal skin or unin-
volved skin from psoriatic patients [23 - 25]. This finding is re-
flected by elevated TGF-a mRNA levels in psoriatic plaques 
[10,24]. Enhanced expression of TGF-a mRNA [24] and protein 
[25] was observed, particularly in psoriatic suprabasal keratinocytes. 
This is the same location in which we found the strongest cytokine-
induced increase of immunoreactive TGF-a in normal epidermis. 
At variance with findings ofTutbitt et al [24], TGF-a immunostain-
ing of basal normal keratinocytes in control explants was weak. 
However, treatment with IL-8 led to detection of elevated TGF-a 
protein levels not only in the suprabasal stratum but also in basal 
keratinocytes. 
Out results suggest that the pattern of the EGF /TGF-a receptor 
and TGF-a expression as observed in psoriasis is not unique to this 
disease, but can be induced in normal neonatal skin and, thus, may 
be comparable to a physiologic response to cytokine stimulation of 
keratinocytes. Activated immune cells such as T-Iymphocytes, 
monocytes/macrophages, and Langerhans cells are obvious sources 
for cytokines such as IFN-y and TNF-a in active psoriatic lesions. In 
fact, Nickoloff et al [9] recently described that TNF-a is expressed 
predominantly by macrophages in the papillary dermis of psoriatic 
lesions, and focally by epidermal Langerhans cells and keratino-
cytes. Suprabasal keratinocytes immediately above dermal TNF-a-
containing macrophages appear to produce IL-8 , suggesting a cas-
cade of cytokine expression involving several cell types. IFN-y is a 
major cytokine released by activated T lymphocytes, and T lympho-
cytes are found at elevated levels in psoriatic skin (26]. Interestingly, 
elevated levels of IFN-y have been reported in sera of patients with 
psoriasis [27], and patients with psoriasis injected with this cytokine 
to treat psoriatic arthropathy developed punctiform psoriatic foci at 
the injection site [28], suggesting a direct involvement of this cyto-
kine in the pathogenesis of skin lesions in psoriasis. In contrast to 
TNF-a and IL-8, IFN-y has not been found to be produced by 
keratinocytes (for review see [29]), although IFN-y mRNA was 
detected in psoriatic epidermis using the sensitive reverse transcrip-
tion polymerase chain reaction [30]. Taken together, these results 
suggest that in psoriatic skin IFN-y may be produced by an epider-
mal cell type other than keratinocytes. 
It should be noted that comparatively high levels of TNF-a 
(500 U /ml) and IFN-y (1000 U /ml) were needed to induce signifi-
cant changes ofTGF-a and EGF /TGF-a receptor expression when 
compared to monolayer cultutes [11]. However, the cytokine con-
centrations used here are comparable to the levels ofIFN-y (100 and 
200 U /ml) required to induce ICAM-l and HLA-OR on keratino-
cytes in situ [31]. By contrast to monolayer cultures, in the explant 
system access of cytokines to target cells is a critical determinant. 
Variables such as size of the skin explant, media composition, and 
modifications in technique may all influence diffusion of cytokines 
into the explant. In support of this notion, Griffiths et al [31] found 
that complete immersion of skin explants in culture medium leads 
to cytokine-induced expression of HLA-OR on keratinocytes, 
whereas partial immersion of primarily the dermal portion does not 
[15]. We chose to use the latter protocol based on the assumption 
that cytokines with possible relevance in vivo would gain access to 
keratinocytes by diffusion from the dermis up. 
Of the other cytokines included in this study, IL-l [32,33] and 
IL-6 [34] have been found at elevated levels or differently distrib-
uted in psoriatic lesions as compared to normal skin. Under the 
experimental conditions chosen in this study, these two cytokines 
did not affect TGF-a or TGF-a/EGF receptor expression detect-
ably. However, the role of these cytokines in these phenomena 
cannot be discounted. Cytokine-induced effects could only be evalu-
ated within a short time period (24 h) after initiation of explant 
cultures. After this time period, cell viability decreased dramatically. 
It appears possible that some cytokines have indirect effects by trig-
gering a sequence of e~ents that require a longer time period to 
evolve. In support of tillS notion, IL-l has been described to stimu-
late the production and release of IL-8 from keratinocytes [35,36]. 
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Our results indicate that the pattern ofTGF-a and EGF /TGF-a 
receptor expression in human epidermis can be modulated by cyto-
kines. Cytokines known to be present in psoriatic lesions enhance 
the intensity and/or expand the distribution of TGF-a and its re-
ceptor in normal epidermis, causing it to resemble the psoriatic 
state. We hypothesize that the altered expression ofTGF-a and its 
receptor observed in psoriatic lesions is secondary to an effect of a 
previously acting cytokine, either produced by infiltrating immune 
cells or the keratinocytes themselves. 
We are gratiful to Dr. G. Trinchierijor supplying neutralizing antibodies to IFN-y 
and TNF-a, to Dr. M. Bevi/aqua jar the ELAM-1 antibody, and to Dr. G.F. 
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